AR074246A1 - Derivados de 1-amino-alquilciclohexano para el tratamiento de trastornos del sueno - Google Patents
Derivados de 1-amino-alquilciclohexano para el tratamiento de trastornos del suenoInfo
- Publication number
- AR074246A1 AR074246A1 ARP090102149A ARP090102149A AR074246A1 AR 074246 A1 AR074246 A1 AR 074246A1 AR P090102149 A ARP090102149 A AR P090102149A AR P090102149 A ARP090102149 A AR P090102149A AR 074246 A1 AR074246 A1 AR 074246A1
- Authority
- AR
- Argentina
- Prior art keywords
- amino
- treatment
- sleep disorders
- tinnitus
- alkylcyclohexane derivative
- Prior art date
Links
- 239000002689 soil Substances 0.000 title 1
- 208000019116 sleep disease Diseases 0.000 abstract 4
- 208000012902 Nervous system disease Diseases 0.000 abstract 3
- 208000025966 Neurological disease Diseases 0.000 abstract 3
- 208000009205 Tinnitus Diseases 0.000 abstract 3
- 230000002265 prevention Effects 0.000 abstract 3
- 231100000886 tinnitus Toxicity 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13178908P | 2008-06-12 | 2008-06-12 | |
| EP08010749 | 2008-06-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR074246A1 true AR074246A1 (es) | 2011-01-05 |
Family
ID=39721946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090102149A AR074246A1 (es) | 2008-06-12 | 2009-06-12 | Derivados de 1-amino-alquilciclohexano para el tratamiento de trastornos del sueno |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20110207793A1 (enExample) |
| EP (1) | EP2315586A1 (enExample) |
| JP (1) | JP5923305B2 (enExample) |
| KR (1) | KR20110005909A (enExample) |
| CN (1) | CN102026633A (enExample) |
| AR (1) | AR074246A1 (enExample) |
| AU (1) | AU2009256905A1 (enExample) |
| BR (1) | BRPI0911920A2 (enExample) |
| CA (1) | CA2722763A1 (enExample) |
| IL (1) | IL209417A0 (enExample) |
| MX (1) | MX2010013450A (enExample) |
| RU (1) | RU2010154623A (enExample) |
| TW (1) | TW201010691A (enExample) |
| WO (1) | WO2009149920A1 (enExample) |
| ZA (1) | ZA201007763B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2596262T3 (es) * | 2007-09-12 | 2017-01-05 | Merz Pharma Gmbh & Co. Kgaa | Derivados de 1-amino-alquilciclohexano para su uso en el tratamiento de tinnitus asociado con pérdida de audición |
| US20110294890A1 (en) * | 2010-05-28 | 2011-12-01 | Merz Pharma Gmbh & Co. Kgaa | Neramexane for the treatment or prevention of inner ear disorders |
| JP5978472B2 (ja) * | 2014-04-28 | 2016-08-24 | 杏林製薬株式会社 | 耳鳴患者の治療用の薬剤 |
| CN113274365B (zh) * | 2021-07-22 | 2021-10-22 | 广东科泰鼎润药业科技有限公司 | 雷美替胺速释缓释双释放制剂及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19528388A1 (de) * | 1995-08-02 | 1997-02-06 | Hans Peter Prof Dr Med Zenner | Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs |
| US6071966A (en) * | 1997-06-30 | 2000-06-06 | Merz + Co. Gmbh & Co. | 1-amino-alkylcyclohexane NMDA receptor antagonists |
| DE69814878T2 (de) * | 1997-06-30 | 2004-05-19 | Merz Pharma Gmbh & Co. Kgaa | 1-amino-alkylcyclohexane als nmda-rezeptor-antagonisten |
| CN100339070C (zh) * | 2002-10-24 | 2007-09-26 | 莫茨药物股份两合公司 | 包含1－氨基环己烷衍生物类和乙酰胆碱酯酶抑制剂类的药物组合物 |
| US20070141148A1 (en) * | 2005-11-30 | 2007-06-21 | Merz Pharma Gmbh & Co. Kgaa | Neramexane MR matrix tablet |
| JP2007246507A (ja) * | 2006-02-15 | 2007-09-27 | Kracie Seiyaku Kk | 疲労の予防・治療組成物及び予防・治療方法 |
| DE102006011922A1 (de) * | 2006-03-15 | 2007-09-20 | Uwe Stoldt | Mittel zur Behandlung von Tinnitus |
-
2009
- 2009-06-09 TW TW098119212A patent/TW201010691A/zh unknown
- 2009-06-10 MX MX2010013450A patent/MX2010013450A/es unknown
- 2009-06-10 JP JP2011512891A patent/JP5923305B2/ja not_active Expired - Fee Related
- 2009-06-10 CN CN2009801170115A patent/CN102026633A/zh active Pending
- 2009-06-10 WO PCT/EP2009/004184 patent/WO2009149920A1/en not_active Ceased
- 2009-06-10 EP EP09761483A patent/EP2315586A1/en not_active Withdrawn
- 2009-06-10 RU RU2010154623/15A patent/RU2010154623A/ru not_active Application Discontinuation
- 2009-06-10 CA CA2722763A patent/CA2722763A1/en not_active Abandoned
- 2009-06-10 AU AU2009256905A patent/AU2009256905A1/en not_active Abandoned
- 2009-06-10 BR BRPI0911920A patent/BRPI0911920A2/pt not_active IP Right Cessation
- 2009-06-10 US US12/737,092 patent/US20110207793A1/en not_active Abandoned
- 2009-06-10 KR KR1020107027774A patent/KR20110005909A/ko not_active Ceased
- 2009-06-12 AR ARP090102149A patent/AR074246A1/es not_active Application Discontinuation
-
2010
- 2010-10-29 ZA ZA2010/07763A patent/ZA201007763B/en unknown
- 2010-11-18 IL IL209417A patent/IL209417A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009256905A1 (en) | 2009-12-17 |
| TW201010691A (en) | 2010-03-16 |
| JP2011522850A (ja) | 2011-08-04 |
| RU2010154623A (ru) | 2012-08-10 |
| EP2315586A1 (en) | 2011-05-04 |
| CA2722763A1 (en) | 2009-12-17 |
| JP5923305B2 (ja) | 2016-05-24 |
| MX2010013450A (es) | 2011-02-23 |
| US20110207793A1 (en) | 2011-08-25 |
| ZA201007763B (en) | 2011-07-27 |
| IL209417A0 (en) | 2011-01-31 |
| BRPI0911920A2 (pt) | 2015-10-06 |
| KR20110005909A (ko) | 2011-01-19 |
| CN102026633A (zh) | 2011-04-20 |
| WO2009149920A1 (en) | 2009-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015029491A2 (pt) | derivados de imidazopirrolidinona e seu uso no tratamento de doença | |
| BR112015029512A8 (pt) | derivados de pirazolopirrolidina, seus usos, e composição e combinação farmacêuticas | |
| MX2015017307A (es) | Uso de pridopidina en dosis altas para el tratamiento de enfermedad de huntington. | |
| BR112015029401A8 (pt) | derivados de pirazolo-pirrolidin-4-ona, seus usos, e composição e combinação farmacêuticas | |
| AR070025A1 (es) | Uso de derivados de 1-amino-alquilciclohexano para el tratamiento del tinnitus coclear y composicion farmaceutica | |
| AR085662A1 (es) | Metodos y composiciones para tratar la hiperuricemia y trastornos metabolicos asociados con la hiperuricemia | |
| PE20142319A1 (es) | Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero | |
| AR090885A1 (es) | Uso de laquinimod en alta dosis para el tratamiento de la esclerosis multiple | |
| BRPI1015539A2 (pt) | composições e métodos para tratamento de queimaduras | |
| AR060019A1 (es) | Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo | |
| UY33277A (es) | Compuestos de anillo espiro-tetraciclico como moduladores de beta-secretasa y métodos de uso | |
| BR112014004741A2 (pt) | pelo menos uma entidade química; composição farmacêutica; uso de uma quantidade terapeuticamente eficaz de pelo menos uma entidade química; composição farmacêutica embalada | |
| CO6270217A2 (es) | Formulaciones galenicas de alisquireno y valsartan | |
| PE20181332A1 (es) | Metodos de sedacion y formulacion parenteral para uso durante el tratamiento de cuidados criticos | |
| AR054249A1 (es) | Tratamiento de enfermedades del tejido conectivo de la piel | |
| AR072951A1 (es) | Uso de dronedarona o una sal aceptable farmaceuticamente de esta, para la preparacion de un medicamento para regular el nivel de potasio en la sangre | |
| AR074246A1 (es) | Derivados de 1-amino-alquilciclohexano para el tratamiento de trastornos del sueno | |
| CL2016001707A1 (es) | Tratamiento de trastornos congnitivos con (r)-7-cloro-n-(quinuclidin-3-il) benzo(b)tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma (div. sol. 1178-11). | |
| ECSP077843A (es) | Tratamiento o prevención del prurito | |
| AR079000A1 (es) | Terapia anticancerosa dirigida a celulas madre cancerosas resistentes a las drogas | |
| AR098832A1 (es) | Uso de laquinimod para retrasar la progresión de la enfermedad de huntington | |
| CL2020001426A1 (es) | Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo. | |
| AR075866A1 (es) | Una dosis de ave5026 para el tratamiento de tromboembolismo venoso en pacientes con deterioro renal severo. uso. composicion farmaceutica. | |
| AR048318A1 (es) | Formulaciones de matriz orales que comprenden licarbazepina | |
| AR088845A1 (es) | Composiciones farmaceuticas que contienen 7-(1h-imidazol-4-ilmetil)-5,6,7,8-tetrahidro-quinolina para el tratamiento de las enfermedades y las afecciones de la piel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |